youtube_live
Q3 2026 earnings
See detailschevron_right
DH:NASDAQ
Definitive Healthcare Corp
$1.13
arrow_downward
-8.13%(-0.10) 1D
$1.15
arrow_upward
+1.77% (+0.020)bedtimeAfter hours
Closed: Nov 5, 4:00:02āÆPM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DH...
Open
$1.23
High
$1.23
Low
$1.05
Mkt. cap
163.67M
Avg. vol.
436.92K
Volume
619.66K
52-wk high
$3.00
52-wk low
$0.61
EPS
-$1.61
Beta
1.40
Shares outstanding
106.74M
No. of employees
682
Open
$1.23
High
$1.23
Low
$1.05
Mkt. cap
163.67M
Avg. vol.
436.92K
Volume
619.66K
52-wk high
$3.00
52-wk low
$0.61
EPS
-$1.61
Beta
1.40
Shares outstanding
106.74M
No. of employees
682
News stories
From web sources and news partners
TradingView
·
3 hours ago
Definitive Healthcare Corp reports results for the quarter ended September 30 - Earnings Summary
Yahoo Finance
·
3 hours ago
Definitive Healthcare Corp. (DH) Tops Q3 Earnings and Revenue Estimates
www.marketscreener.com
·
6 hours ago
Definitive Healthcare Reports Financial Results for Third Quarter 2026
Profile
Definitive Healthcare, Corp. is a publicly traded healthcare data and analytics company headquartered in Framingham, Massachusetts, United States. The company operates subscription-based products and solutions with data on healthcare organizations, providers, services, medical and scientific experts, claims, and consumers.
Definitive Healthcare supports life sciences, healthcare providers, software and IT, consulting, financial services, and other organizations operating within the healthcare market. Wikipedia
About Definitive Healthcare Corp
CEO-
Employees682
Founded2011
HeadquartersFramingham, Massachusetts, United States
SectorHealth Care
Industry-
Websitedefinitivehc.com
Analyst ratings
Based on 8 analysts giving stock ratings to DH in the past 3 months
Hold
Buy
1
Hold
5
Sell
2
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for DH in the last 3 months.
Highest
Current $1.13
$3.00 (+165.49%)
Average
$1.70 (+50.44%)
Lowest
$0.70 (-38.05%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
David Larsen BTIG | Hold | Reiterated | - | - | 09/03/2026 |
David Grossman Stifel Nicolaus | Buy | Maintained | $3.00 | +165.5% | 09/03/2026 |
Craig Hettenbach Morgan Stanley | Hold | Maintained | $1.50 | +32.7% | 09/03/2026 |
Ryan MacDonald Needham | Hold | Reiterated | - | - | 09/02/2026 |
Glen Santangelo Barclays | Sell | Maintained | $1.00 | -11.5% | 08/21/2026 |
George Hill Deutsche Bank | Hold | Maintained | $1.00 | -11.5% | 08/12/2026 |
Allen Lutz Bank of America Securities | Sell | Reiterated | $0.70 | -38.1% | 08/11/2026 |
David Hynes Canaccord Genuity | Hold | Maintained | $3.00 | +165.5% | 08/11/2026 |
Joseph Vruwink Robert W. Baird | Hold | Maintained | $1.10 | -2.7% | 05/08/2026 |
Jared Haase William Blair | Buy | Reiterated | - | - | 05/07/2026 |
Jeffrey Garro Stephens | Hold | Maintained | $3.00 | +165.5% | 02/27/2026 |
Awaiting results...
Call Time: Thu, Nov 5, 11:00āÆPM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.04
Revenue / Est. (USD)
- / 54.58M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 60.05M | 61.53M | 55.93M | 55.20M |
Cost of goods sold | 9.07M | 9.94M | 9.36M | 9.42M |
Cost of revenue | 9.07M | 9.94M | 9.36M | 9.42M |
Research and development expenses | 7.55M | 9.95M | 6.50M | 6.76M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 32.74M | 34.46M | 31.66M | 29.96M |
Operating expense | 54.36M | 58.30M | 51.41M | 50.50M |
Total operating expenses | 63.43M | 68.25M | 60.76M | 59.92M |
Operating income | -3.38M | -6.72M | -4.84M | -4.72M |
Other non operating income | -7.25M | 12.71M | 6.83M | 26.00K |
EBT including unusual items | -17.27M | -17.20M | -195.79M | -7.80M |
EBT excluding unusual items | -11.96M | 2.71M | 665.00K | -5.77M |
Income tax expense | 524.00K | -53.00K | -3.44M | -345.00K |
Effective tax rate | -3.03% | 0.31% | 1.75% | 4.42% |
Other operating expenses | - | - | - | - |
Net income | -14.84M | -9.32M | -138.62M | -5.42M |
Net profit margin | -24.71% | -15.14% | -247.85% | -9.82% |
Earnings per share | 0.07 | 0.06 | 0.06 | 0.05 |
Interest and investment income | 1.67M | 1.48M | 1.30M | 1.25M |
Interest expense | -3.00M | -2.87M | -2.63M | -2.63M |
Net interest expenses | -1.33M | -1.38M | -1.33M | -1.38M |
Depreciation and amortization charges | 9.08M | 9.21M | 8.32M | 8.54M |
EBITDA | 10.68M | 7.18M | 8.41M | 9.06M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events